GLUCOCARD ELITE
LIVE

Serial Number

79412653

Owner

ARKRAY, Inc.

Attorney

Michael T. Olsen

Filing Date

Oct 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GLUCOCARD ELITE Trademark

Serial Number: 79412653 • Registration: 8190721

GLUCOCARD ELITE is a trademark filed by ARKRAY, Inc. on October 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ARKRAY, Inc.

57, Nishi Aketa-cho, Higashi-kujo
Kyoto 601-8045 , JP

Entity Type: 03

Trademark Details

Filing Date

October 21, 2024

Registration Date

March 31, 2026

Published for Opposition

February 10, 2026

Goods & Services

Medical diagnostic apparatus for measuring and testing blood glucose levels, and their parts and accessories, namely, medical specimen collection devices in the nature of lancets for collecting blood; medical diagnostic testing apparatus for measuring and testing blood glucose levels; blood testing apparatus; blood glucose testing apparatus for medical purposes, namely, devices for monitoring blood glucose for medical purposes; blood glucose meters; blood glucose meters used in conjunction with downloadable application software for measuring blood glucose levels; medical test kits for measuring blood glucose levels comprised of blood glucose meter and test strips

Laboratory apparatus and instruments for measuring blood glucose levels, not for medical purposes; diagnostic sensor chips for medical purposes; diagnostic sensor chips for medical purposes for measuring blood glucose levels; telecommunication machines and apparatus for data management, namely, wireless transmitters and receivers for use in the collection and analysis of patient healthcare data; downloadable computer software for data management, data collection and analysis of patient healthcare data; downloadable computer software for measuring and analyzing of blood glucose levels; recorded computer software for data management, data collection and analysis of patient healthcare data; recorded computer software for use in measuring and analyzing of blood glucose levels; downloadable image files containing information about blood glucose monitoring

Diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; medical diagnostic test strips for blood analysis; test strips for measuring blood glucose levels; plastic medical diagnostic test strips primarily comprising an electrode and diagnostic reagents for use in measuring blood glucose levels

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 4, 2026 OPNX
TEAS SECTION 7 REQUEST RECEIVED
May 21, 2026 ES7R
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 18, 2026 OPNR
POST PUBLICATION AMENDMENT – NOT ENTERED
Apr 20, 2026 CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
Apr 20, 2026 CHPN
ASSIGNED TO PETITION STAFF
Apr 14, 2026 APET
ASSIGNED TO PETITION STAFF
Apr 13, 2026 APET
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 23, 2026 EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Feb 18, 2026 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Feb 5, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 21, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 20, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 14, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 14, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 14, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 14, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 10, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 10, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2025 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 22, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2025 COAR
REFUSAL PROCESSED BY IB
Apr 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 31, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 26, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2024 REPR